Juno Therapeutics, Inc.;The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
发明人:
SITKOVSKY, Michail V.,THIEL, Manfred
申请号：
ES06733918
公开号：
ES2630232T8
申请日:
2006.01.26
申请国别(地区):
ES
年份:
2017
代理人:
摘要：
Methods for modulating responsiveness to increased oxygen levels in an at-risk subject identifying an at-risk subject； and before exposing the identified at-risk subject to an increased amount of oxygen, administering to the at-risk subject an anti-inflammatory agent wherein the responsiveness of the at-risk subject to said increased amount of oxygen is modulated as compared to the responsiveness of the at-risk subject to said increased amount of oxygen in the absence of said anti-inflammatory.
